Carpal Tunnel Hydrodissection vs Surgery: What the Evidence Shows
Short Answer
- Carpal tunnel hydrodissection is an ultrasound-guided injection that separates the median nerve from the ligament and tissue compressing it, without cutting anything. Carpal tunnel release surgery cuts the ligament to make room for the nerve
- No trial compares the two head to head. Randomized trials of hydrodissection indicate improvement in pain, function, and nerve swelling at 6 months, and long-term cohorts report most patients still doing well 2 or more years later
- At Regenerative Performance, nerve hydrodissection is preferred for mild-to-moderate carpal tunnel syndrome, and surgical release is reserved for a genuine failure of well-targeted non-surgical care
Both treatments take pressure off the median nerve: hydrodissection with an ultrasound-guided injection and a recovery measured in days, surgery with a cut ligament and a recovery measured in weeks, and the severity of your compression plus what you have already tried decide which one comes first.
This guide is for you if you want to compare nerve hydrodissection, a non-surgical treatment for carpal tunnel syndrome, with carpal tunnel release surgery before you commit to either.
If your fingers go numb at night, your hand aches by the end of a workday, and the last visit ended with "we can try a cortisone injection, and if that doesn't work or wears off, surgical release," you have been handed the same options most people in the insurance-based medical system with carpal tunnel syndrome get. That path starts with night splinting, activity modification, and physical therapy, moves on to a steroid injection, and ends at surgical release. You have probably already worn the splint and maybe had a steroid injection that faded, but the option that rarely comes up is the one that addresses the compression directly without cutting the ligament, and the evidence behind it is stronger than most people are told.
Carpal tunnel hydrodissection is an ultrasound-guided injection that uses fluid, most often your own platelet-rich plasma (PRP), protein concentrate, or both, to separate the median nerve from the transverse carpal ligament and connective tissue compressing it at the wrist. Carpal tunnel release surgically cuts that ligament to relieve the same compression. No trial has compared the two directly, so the choice rests on separate evidence for each, on how severe the compression is, and on what you have already tried. At Regenerative Performance in Gilbert, AZ, a hands-on exam and diagnostic ultrasound determine how severe the compression is before either path is recommended.
If you have hand pain, numbness, or tingling that has not improved with splinting, therapy, or cortisone, the next step is a detailed, in-person assessment to identify exactly where the median nerve is compressed and to review nerve hydrodissection before surgery is on the table.
Schedule a 2-hour evaluation for your hand pain, numbness, or tingling at our Gilbert, AZ clinic (also serving Chandler, Mesa, Queen Creek, and the greater Phoenix area).
We limit how many new regenerative patients we accept each month to devote sufficient time and attention to each case.
Patients travel to Gilbert from across the East Valley and from out of state for nerve hydrodissection, usually after a steroid injection has been tried and a surgical consult has been offered. What they find here is a different first step, confirming that the median nerve at the wrist is actually the structure generating the symptoms.
Key Facts About Carpal Tunnel Hydrodissection vs Surgery
Here is what you need to know about carpal tunnel hydrodissection and carpal tunnel surgery before deciding which fits your situation.
- What hydrodissection is: An ultrasound-guided injection of fluid around the median nerve, typically properly dosed platelet-rich plasma (PRP), protein concentrate, or both, often with 5% dextrose added, that lifts the compressing ligament off the nerve so it can glide better.
- What surgery is: Carpal tunnel release, done open or endoscopically, cuts the transverse carpal ligament to make more room for the median nerve.
- Who hydrodissection helps: Adults with pain, numbness, or tingling in the thumb, index, middle, and ring fingers originating from compression of the median nerve at the wrist, who have not improved with splinting, therapy, or a steroid injection and want a non-surgical option first.
- How hydrodissection works: Fluid injected under continuous ultrasound guidance separates the median nerve from the transverse carpal ligament and the surrounding tissue, relieving the compression so the nerve can glide better.
- Key difference: No trial directly compares hydrodissection to surgery. Hydrodissection recovery is measured in days, while surgical recovery is measured in weeks, and surgery's outcome literature has been followed for longer. Individual results may vary.
- Where it is done: Regenerative Performance, Gilbert, AZ, serving patients across Chandler, Mesa, and the greater Phoenix area.
- Next step: Call 480-508-4226 to schedule a 2-hour evaluation for hand pain, numbness, or tingling in Gilbert, AZ.
Is My Hand Pain Carpal Tunnel Syndrome?
Hand pain is carpal tunnel syndrome when the median nerve is compressed where it passes under the transverse carpal ligament at the wrist, and the symptoms follow that nerve, showing up as numbness, tingling, or aching in the thumb, index finger, middle finger, and the thumb side of the ring finger. Symptoms that wake you at night, a hand you shake out, and a weakening grip are the classic pattern, but several other problems can look similar, so the pattern alone does not settle the diagnosis.
Confirming the diagnosis starts with your history and a hands-on physical exam, and a neuromusculoskeletal screen of the forearm, elbow, and neck for conditions that mimic carpal tunnel. Diagnostic musculoskeletal ultrasound then shows the nerve directly. In our experience, a compressed median nerve typically looks flattened where the ligament crosses it and swollen just upstream. Research suggests a nerve cross-sectional area (how thick a slice of the nerve measures on the ultrasound image) of 14 mm2 or greater at the tunnel entrance, combined with a stiffness measurement, helps separate moderate and severe cases from milder ones (Moran et al., Journal of Ultrasound in Medicine, 2019).
The image only counts when it matches your symptoms. Part of the exam is pressing directly under the probe on the swollen segment, because reproducing your familiar symptoms there is what helps identify that segment as the source when it is put together with your history and physical exam. A diagnostic nerve block is a selective add-on when the primary complaint is pain and its source is genuinely unclear. When the primary complaint is numbness, a diagnostic block is unnecessary, because the hand is already numb.
One detail changes the plan more often than people expect. A small branch of the median nerve, the palmar cutaneous branch, supplies the skin over the base of the palm, and it leaves the main nerve above the wrist, before the carpal tunnel. If your symptoms include the base of your palm, the problem may sit above the wrist rather than inside the tunnel. Sometimes that branch needs to be hydrodissected in addition to the median nerve in the tunnel itself, or the nerve entrapment may be further up the forearm or arm.
How Does Carpal Tunnel Hydrodissection Work?
Carpal tunnel hydrodissection works by injecting fluid, under ultrasound guidance, into the plane between the median nerve and the ligament and connective tissue pressing on it. As the fluid separates the nerve from that tissue, a complete ring of fluid appears around the nerve on the ultrasound screen, and that ring is the confirmation that the nerve has been fully hydrodissected along the compressed segment, so it may glide better and its blood supply may be less restricted. Part of the benefit may come from relieving pressure on the small vessels and nerve fibers that supply the nerve itself, not only its main bundles (Lam et al., Journal of Pain Research, 2020).
Nerve hydrodissection can be performed with several different solutions, including saline, 5% dextrose in water (D5W), platelet-rich plasma (PRP), protein concentrate, and stem cell therapy in the form of bone marrow concentrate or microfragmented adipose tissue. Because the whole procedure is ultrasound-guided, the fluid is injected at the exact segment where the nerve is compressed rather than somewhere along its general course. At Regenerative Performance the injectate is typically properly dosed PRP, protein concentrate, or both, depending on your diagnosis, often with 5% dextrose added. Dextrose on its own is used in a small minority of cases, and we do not use saline, as the evidence indicates that D5W and PRP result in greater improvement than saline.
Important note: In the United States, PRP for nerve entrapment is typically an off-label use of devices cleared to prepare platelet concentrates, not an FDA-approved treatment for nerve entrapment. 5% dextrose is an FDA-approved injectable solution for other uses and is applied off-label for nerve hydrodissection. Individual results may vary.
What Does the Evidence Show for Carpal Tunnel Hydrodissection?
The evidence for carpal tunnel hydrodissection comes from randomized trials that measure 6 to 12 months of follow-up, a pooled analysis of those trials, and long-term cohorts that follow patients for 2 years or more. Most patients improve, the improvement holds through the trial windows that were measured, and the procedure carries a low complication rate.
Six-month randomized trials
A randomized trial of 60 patients with mild-to-moderate carpal tunnel syndrome indicated that a single ultrasound-guided injection of 3 mL of PRP produced greater improvement than a night splint in pain at 6 months and in nerve swelling at every follow-up, with the functional score also favoring PRP at every visit (Wu et al., Scientific Reports, 2017). In a placebo-controlled trial, 76.9% of patients treated with a single PRP injection reached the study's success threshold on a hand-function score at 12 weeks, compared with 33.3% after a saline placebo, with no serious side effects (Malahias et al., Journal of Tissue Engineering and Regenerative Medicine, 2018).
In moderate-to-severe cases, a randomized trial indicates a single PRP injection produces significantly greater symptom improvement than the control treatment at every time point through 12 months (Chen et al., Archives of Physical Medicine and Rehabilitation, 2021), and a head-to-head trial in moderate carpal tunnel syndrome suggests PRP reduces nerve swelling more than a comparable dextrose injection at 3 and 6 months (Shen et al., Journal of Tissue Engineering and Regenerative Medicine, 2019). A systematic review (a study that combines results from many separate studies) combined data from 20 controlled trials, and it suggests that ultrasound-guided injection with 5% dextrose improves symptoms and function significantly more than steroid or saline injection, and that PRP significantly reduces symptom severity and improves function versus the control treatments used in those trials (Lam et al., Diagnostics, 2023).
Two to five years out
A cross-sectional cohort assessed 81 patients at least 2 years after a single PRP injection, and 70.37% reported an effective outcome. Sorted by baseline severity, the effective-outcome rate was 91.7% in mild carpal tunnel syndrome, 71.2% in moderate, and 40% in severe (Lai et al., Pain Medicine, 2022). This study suggests that patients with milder carpal tunnel syndrome are more likely to improve, but severe cases may still be candidates if the goal is to avoid surgery.
A retrospective series of 185 patients followed 1 to 3 years after ultrasound-guided 5% dextrose injections reported an effective outcome in 88.6%, with no complications in any patient, and among those with a poorer outcome only two went on to surgery (Li et al., Rheumatology, 2020).
After a failed or recurrent carpal tunnel surgery
A prospective cohort study followed 100 patients whose carpal tunnel symptoms persisted or returned after carpal tunnel release surgery and who then received 1 to 4 ultrasound-guided dextrose hydrodissection treatments. Treatment success was reached by 58% of them at 6 months and by 52.0% at 12 months, with better results in those whose symptoms had recurred than in those whose symptoms never resolved, and no serious treatment-related adverse events (Popescu et al., Diagnostics, 2026).
In a retrospective series of 185 patients treated with ultrasound-guided 5% dextrose (Li et al., Rheumatology, 2020), a smaller group of patients had a prior failed carpal tunnel surgery or a post-surgical recurrence, and 80% of them reported an effective outcome. These studies suggest that even after surgical release has been performed, nerve hydrodissection can still be effective.
Schedule a 2-hour evaluation for your hand pain, numbness, or tingling at our Gilbert, AZ clinic.
What Does the AAOS Guideline Say About Carpal Tunnel Hydrodissection?
The AAOS guideline does not endorse carpal tunnel hydrodissection. The 2024 clinical practice guideline on managing carpal tunnel syndrome from the American Academy of Orthopaedic Surgeons, endorsed by the American Society for Surgery of the Hand, lists hydrodissection and perineural injection therapy among non-operative treatments that, in its reading of the evidence, do not improve long-term patient-reported outcomes, a recommendation the guideline itself grades as limited strength. It grades a separate statement, that PRP injection does not provide long-term benefits in non-operative treatment of carpal tunnel syndrome, as strong evidence. The same document endorses a clinical scoring tool, the CTS-6, for diagnosis in lieu of routine ultrasound or nerve-conduction testing, and it recommends against steroid injection for long-term improvement (Shapiro et al., Journal of the American Academy of Orthopaedic Surgeons, 2024).
The randomized trials of nerve hydrodissection followed patients for 6 to 12 months and consistently indicated improvement, and in the long-term cohorts reported by Lai et al. and Li et al., most patients still reported improvement, with the caveat that both are uncontrolled. The AAOS grades injection treatments, including hydrodissection and PRP, mainly on long-term results. It did review hydrodissection studies indicating benefit at three to six months, and it graded the recommendation as limited strength because the treatments, study quality, comparison groups, and follow-up periods varied across the studies it grouped together. A limited-strength conclusion about long-term outcomes does not establish that nerve hydrodissection fails to relieve symptoms over the shorter windows those trials actually measured. In our experience, most patients with a confirmed median-nerve compression improve after a well-targeted hydrodissection, and that improvement is what we track, patient by patient, before anything else is recommended.
How Does Carpal Tunnel Release Surgery Work?
Carpal tunnel release surgery works by cutting the transverse carpal ligament, the band of tissue that forms the roof of the tunnel, so the median nerve has more room. It can be done through a small open incision at the base of the palm or endoscopically, through one or two smaller portals with a camera.
Surgery is a mechanical solution to a mechanical problem, and for the right patient it can work.
What Does the Evidence Show for Carpal Tunnel Release Surgery?
The evidence indicates that carpal tunnel release surgery relieves symptoms and improves hand function for most people, with results measured within months of the operation in pooled outcome studies and over years in observational cohorts. A meta-analysis (a study that combines results from many earlier studies into one estimate) of 17 studies of endoscopic release across 13 countries indicated that, in the 7 studies tracking the QuickDASH, a questionnaire where a lower score means less difficulty with everyday hand use, scores improved by an average of 28.8 points over a median follow-up of 4 months (Miller et al., Journal of Hand Surgery Global Online, 2023).
For scale, the QuickDASH runs from 0 to 100, so a 28.8-point drop is more than a quarter of the whole range.
In the Miller et al. meta-analysis of 17 endoscopic-release studies, conversion to open surgery occurred in 0.7% of cases, postsurgical complications in 0.7%, and reoperation in 0.5% (Miller et al., Journal of Hand Surgery Global Online, 2023). Its authors note that every combined outcome was measured within 4 to 7 months and that limited high-quality evidence supports long-term utility.
Longer follow-up after carpal tunnel release
In an interview cohort averaging 11 years after carpal tunnel release, 73.1% of patients reported complete resolution of symptoms and functional limitations (Krieger et al., International Journal of Environmental Research and Public Health, 2024). Between the two techniques, combined data from randomized trials suggest endoscopic release returns people to work about a week sooner and results in fewer scar-related complications, but carries a higher rate of transient nerve injury. Permanent nerve injury rates did not differ significantly between the two techniques (Li et al., BMC Musculoskeletal Disorders, 2020). The Cochrane review, whose reviewers assess trial quality before drawing conclusions, is the most cautious summary: surgery probably results in a higher rate of clinical improvement than splinting, and the reviewers were reasonably confident in that finding (Lusa et al., Cochrane Database of Systematic Reviews, 2024).
When Is Carpal Tunnel Surgery the Right Call?
Carpal tunnel surgery is the right call when the median nerve has been compressed long or hard enough that the muscles at the base of the thumb are visibly wasting, when sensory testing shows the nerve no longer responds, or when appropriate non-surgical care, including a well-targeted nerve hydrodissection, has genuinely failed. Some patients also reasonably prefer a single definitive procedure after understanding both paths.
Surgical release is not part of our usual first pathway. A referral follows a well-supported diagnosis and a genuine failure of non-surgical care, never a bare imaging finding. When surgery is the right call, we say so, and a prior hydrodissection leaves the ligament intact, so nothing about it complicates the operation.
Carpal Tunnel Hydrodissection vs Surgery: Quick Decision Guide
- If your carpal tunnel syndrome is mild to moderate, with no muscle wasting at the base of the thumb, and you want a non-surgical option first, nerve hydrodissection is a reasonable starting point.
- If you have severe carpal tunnel syndrome with visible wasting of the thumb muscles or a hand that has lost complete sensation, a surgical evaluation belongs early in the plan.
- If a steroid injection helped and then wore off, both options remain open. Our usual pathway is nerve hydrodissection before any surgical referral.
- If your symptoms persisted or came back after carpal tunnel surgery, hydrodissection has published evidence in exactly that situation.
Hydrodissection vs Surgery: Results Over Time
Hydrodissection and surgery differ less in whether patients improve than in what each one does to the wrist, how fast the recovery is, and how long the evidence behind each has been followed.
| Feature | Nerve hydrodissection | Carpal tunnel release |
|---|---|---|
| What it does | Injects fluid that separates the median nerve from the ligament and connective tissue compressing it | Surgically cuts the transverse carpal ligament, open or endoscopically |
| Setting | Office procedure under ultrasound guidance with local anesthetic | Operating room or office, usually local anesthesia |
| Return to daily activities | Same day to a few days; mild soreness if any | Days to weeks, sooner with endoscopic technique |
| Controlled-trial follow-up | Randomized trials at 6 to 12 months versus splint, saline, or steroid injection | Randomized trials versus splint and steroid injection; pooled outcome studies at 4 to 7 months |
| Long-term follow-up | Uncontrolled cohorts at 1 to 5 years | Trial extensions at 6 years and observational cohorts at 11 years |
| Best fit | Mild-to-moderate compression; a first option before surgery; symptoms after a prior release | Severe compression with thumb-muscle wasting or complete loss of sensation; failure of well-targeted non-surgical care |
| If it does not work | The diagnosis is re-examined; surgery remains fully available | Revision surgery, or hydrodissection, which has published results in post-surgical cases |
Who Is a Good Candidate for Carpal Tunnel Hydrodissection?
A good candidate for carpal tunnel hydrodissection is an adult whose hand pain, numbness, or tingling follows the median nerve, whose exam and ultrasound confirm compression at the wrist or just above it, and who wants a non-surgical option before, or instead of, cutting the ligament. Severity matters, because in the long-term PRP cohort reported by Lai et al., effective outcomes were most common in mild and moderate cases, and severe compression is where the surgical conversation starts earlier.
If you recognize yourself in the list below, hydrodissection may be worth exploring.
- Numbness, tingling, or aching in the thumb, index, middle, or ring fingers, often worse at night or after gripping
- A wrist splint, activity changes, or hand therapy that helped a little or not at all
- A steroid injection that helped for a while and then wore off, or one you would rather not have
- A surgical consult you are not ready to act on, or a wish to avoid surgery altogether
- Symptoms that persisted or returned after a previous carpal tunnel release
Hydrodissection is unlikely to be the right first step if the muscles at the base of your thumb are visibly wasting, if the nerve no longer responds on testing, or if the exam points to a different source, such as the neck or the elbow. Our clinic is in Gilbert, AZ. Patients travel in from out of state and internationally, and the evaluation and the procedure can be scheduled in a single trip.
Next Step: The 2-Hour Carpal Tunnel Evaluation in Gilbert, AZ
One visit, built to find out how compressed the median nerve actually is and which path fits. You get:
- A hands-on exam of the wrist, forearm, elbow, and neck that reproduces your familiar symptoms so the source can be narrowed down rather than assumed
- Diagnostic musculoskeletal ultrasound of the median nerve, including the branch above the wrist
- A clear plan, whether that is nerve hydrodissection, another non-surgical option, or a surgical referral if that is the right call
- A straight answer if hydrodissection is not likely to help you
What to Expect at a Carpal Tunnel Evaluation in Gilbert, AZ
Regenerative Performance is located in Gilbert, AZ. The evaluation is a single 2-hour visit that follows the same order for every patient, starting with history, then the exam, then imaging.
You describe where the symptoms are, when they show up, and what you have tried. The hands-on exam maps the sensation in each finger and the base of the palm, checks grip and thumb strength, runs the provocation maneuvers, and screens the forearm, elbow, and neck for conditions that mimic carpal tunnel syndrome. The provider then scans the median nerve from the forearm into the palm, measures it at the tunnel entrance, and checks the palmar cutaneous branch above the wrist, pressing under the probe to see whether the suspect segment reproduces your familiar symptoms, which is how the finding on the screen is tied to the problem in your hand.
If the exam and ultrasound agree that the compression is mild to moderate, nerve hydrodissection is usually the first recommendation, and for traveling patients it can often be done in the same trip. If the picture points to severe compression, or to a different source entirely, you hear that instead, along with what it means for the plan.
What We See in Practice With Carpal Tunnel Hydrodissection
In our practice, a carpal tunnel hydrodissection is one treatment followed by tracking, not a series. Most patients have no soreness afterward. When there is mild soreness at the injection site, it lasts a day or two, and only very rarely is there a pain flare that lasts most of a week before settling.
Most patients notice a change within the first 2 weeks, and some take longer. With PRP or protein concentrate, the response typically plateaus by 8 to 12 weeks, so that is the window we track before deciding anything. In the uncommon case where dextrose alone is used, the plateau tends to arrive around 4 to 6 weeks.
If there is no response after one well-targeted treatment, the first question is not whether to repeat it. It usually means the diagnosis was wrong, or there is a true mechanical compression the fluid did not adequately relieve. Either way, we go back to the history, repeat the exam, and consider further imaging before recommending the next step. Some patients come to us as a last resort before surgery, and for a few of them, surgery becomes the recommendation.
If you are unsure whether orthobiologic injections like PRP or stem cell therapy are appropriate, or you are traveling from outside the Phoenix area, you can also call and ask about a brief 15 minute discovery call.
Frequently Asked Questions About Carpal Tunnel Hydrodissection
How successful is carpal tunnel hydrodissection?
Carpal tunnel hydrodissection improves pain, hand function, and nerve swelling in most patients in the published trials, with the strongest results in mild and moderate cases. Randomized trials measured that improvement at 6 to 12 months, and a long-term cohort suggests roughly seven in ten patients still reporting an effective outcome 2 or more years after a single PRP injection, though that cohort had no comparison group. Success depends heavily on confirming that the median nerve is truly the source before it is treated.
Does carpal tunnel hydrodissection work for severe cases?
Carpal tunnel hydrodissection works less reliably for severe cases than for mild and moderate ones. In the long-term PRP cohort, the effective-outcome rate fell to 40% in severe cases compared with more than 70% in moderate ones, and severe nerve involvement predicted lower odds of success after prior surgery as well. Severe compression with thumb-muscle wasting or lost sensation is where a surgical evaluation belongs early in the plan.
How long is recovery after carpal tunnel hydrodissection?
Recovery from carpal tunnel hydrodissection takes a day or two at most, because nothing is cut. Most patients have no increase in symptoms, and mild soreness at the injection site settles within a couple of days. Normal daily activities resume the same day or the next, with the improvement in numbness and pain building over the following weeks rather than arriving all at once.
Is carpal tunnel hydrodissection painful?
Carpal tunnel hydrodissection is not usually painful, because local anesthetic is used and the injection is guided by ultrasound to the exact plane around the nerve. Patients often feel pressure or a brief tingling into the fingers as the fluid is injected around the median nerve. Afterward most have no soreness, and when soreness occurs it is mild and short-lived.
What injectates are used for carpal tunnel hydrodissection?
Carpal tunnel hydrodissection can be performed with saline, 5% dextrose in water (D5W), platelet-rich plasma (PRP), protein concentrate, or stem cell therapy in the form of bone marrow concentrate or microfragmented adipose tissue. Published trials support PRP and dextrose individually, and a head-to-head trial in moderate carpal tunnel syndrome indicates PRP reduces nerve swelling more than dextrose at 3 and 6 months. At Regenerative Performance, the injectate is typically properly dosed PRP, protein concentrate, or both, depending on your diagnosis, often with 5% dextrose added, and we do not use saline.
Does carpal tunnel hydrodissection help if symptoms come back after surgery?
Carpal tunnel symptoms that come back after surgery can still respond to nerve hydrodissection, which has published evidence in exactly that situation. In a cohort of post-surgical patients treated with ultrasound-guided dextrose hydrodissection, 58% had treatment success at 6 months, with better results when the symptoms had improved after surgery and then recurred than when they never improved at all. Scar tissue around the nerve after a release is a common reason, and it is visible on ultrasound.
Who should not get carpal tunnel hydrodissection?
Carpal tunnel hydrodissection is not the right first step for someone with visible wasting of the thumb muscles, a nerve that no longer responds on testing, or symptoms that the exam traces to the neck, the elbow, or a condition other than nerve compression. In those cases the plan changes to match the diagnosis, which may mean a surgical evaluation or treatment of a different structure entirely.
Is carpal tunnel hydrodissection covered by insurance in Arizona?
Carpal tunnel hydrodissection with PRP or protein concentrate is typically not covered by insurance as it is deemed experimental. Regenerative Performance is a cash-pay practice. Cost depends on the number and complexity of structures treated, and the specifics are reviewed during the 2-hour evaluation once the diagnosis is clear.
Still have questions? The best way to get answers is a conversation. Call 480-508-4226.
Schedule a 2-hour evaluation for your hand pain, numbness, or tingling at our Gilbert, AZ clinic.
About Dr. Drew Timmermans
Dr. Drew Timmermans, ND, RMSK
Dr. Drew Timmermans, ND, RMSK, is a naturopathic physician and registered musculoskeletal sonographer (RMSK) practicing at Regenerative Performance in Gilbert, AZ. He specializes in orthobiologic injections, including PRP, stem cell therapy, prolotherapy, and nerve hydrodissection, using ultrasound and x-ray guidance to treat the specific structures causing chronic pain rather than suppressing symptoms.
Patients from across Arizona and out of state see him for chronic joint, tendon, and nerve pain that has not responded to physical therapy, cortisone, or standard orthopedic care. Every new patient receives a 2-hour evaluation with a hands-on, tissue-level diagnosis using diagnostic ultrasound.
References
- Wu YT, Ho TY, Chou YC, Ke MJ, Li TY, Huang GS, Chen LC. Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: A prospective randomized, single-blind controlled trial. Scientific Reports. 2017;7:94. DOI: 10.1038/s41598-017-00224-6.
- Malahias MA, Nikolaou VS, Johnson EO, Kaseta MK, Kazas ST, Babis GC. Platelet-rich plasma ultrasound-guided injection in the treatment of carpal tunnel syndrome: A placebo-controlled clinical study. Journal of Tissue Engineering and Regenerative Medicine. 2018;12(3):e1480-e1488. DOI: 10.1002/term.2566.
- Chen SR, Shen YP, Ho TY, Li TY, Su YC, Chou YC, Chen LC, Wu YT. One-Year Efficacy of Platelet-Rich Plasma for Moderate-to-Severe Carpal Tunnel Syndrome: A Prospective, Randomized, Double-Blind, Controlled Trial. Archives of Physical Medicine and Rehabilitation. 2021;102(5):951-958. DOI: 10.1016/j.apmr.2020.12.025.
- Shen YP, Li TY, Chou YC, Ho TY, Ke MJ, Chen LC, Wu YT. Comparison of perineural platelet-rich plasma and dextrose injections for moderate carpal tunnel syndrome: A prospective randomized, single-blind, head-to-head comparative trial. Journal of Tissue Engineering and Regenerative Medicine. 2019;13(11):2009-2017. DOI: 10.1002/term.2950.
- Lam KHS, Wu YT, Reeves KD, Galluccio F, Allam AE, Peng PWH. Ultrasound-Guided Interventions for Carpal Tunnel Syndrome: A Systematic Review and Meta-Analyses. Diagnostics. 2023;13(6):1138. DOI: 10.3390/diagnostics13061138.
- Lai CY, Li TY, Lam KHS, Chou YC, Hueng DY, Chen LC, Wu YT. The Long-Term Analgesic Effectiveness of Platelet-Rich Plasma Injection for Carpal Tunnel Syndrome: A Cross-Sectional Cohort Study. Pain Medicine. 2022;23(7):1249-1258. DOI: 10.1093/pm/pnac011.
- Li TY, Chen SR, Shen YP, Chang CY, Su YC, Chen LC, Wu YT. Long-term outcome after perineural injection with 5% dextrose for carpal tunnel syndrome: a retrospective follow-up study. Rheumatology. 2021;60(2):881-887. DOI: 10.1093/rheumatology/keaa361.
- Popescu S, Căpeț A, Săvulescu SE, Popescu C, Berteanu M. Ultrasound-Guided 5% Dextrose Hydrodissection Procedures for Persistent and Recurrent Post-Surgical Carpal Tunnel Syndrome: A Prospective Single-Center Cohort Study. Diagnostics. 2026;16(13):2106. DOI: 10.3390/diagnostics16132106.
- Lam KHS, Hung CY, Chiang YP, Onishi K, Su DCJ, Clark TB, Reeves KD. Ultrasound-Guided Nerve Hydrodissection for Pain Management: Rationale, Methods, Current Literature, and Theoretical Mechanisms. Journal of Pain Research. 2020;13:1957-1968. DOI: 10.2147/jpr.s247208.
- Moran L, Royuela A, de Vargas AP, Lopez A, Cepeda Y, Martinelli G. Carpal Tunnel Syndrome: Diagnostic Usefulness of Ultrasound Measurement of the Median Nerve Area and Quantitative Elastographic Measurement of the Median Nerve Stiffness. Journal of Ultrasound in Medicine. 2020;39(2):331-339. DOI: 10.1002/jum.15111.
- Shapiro LM, Kamal RN, Brault J, Chen K, et al. American Academy of Orthopaedic Surgeons Clinical Practice Guideline Summary Management of Carpal Tunnel Syndrome. Journal of the American Academy of Orthopaedic Surgeons. 2024. DOI: 10.5435/jaaos-d-24-01179.
- Miller LE, Hammert WC, Chung KC, et al. Best-Evidence Systematic Review and Meta-Analysis of Endoscopic Carpal Tunnel Release Outcomes. Journal of Hand Surgery Global Online. 2023;5(6):769-773. DOI: 10.1016/j.jhsg.2023.07.011.
- Krieger Y, Ofri M, Sagi G, Moshe-Noach H, et al. Long-Term Functional Outcomes and Quality of Life Following Carpal Tunnel Release Surgery. International Journal of Environmental Research and Public Health. 2024;21(9):1203. DOI: 10.3390/ijerph21091203.
- Li Y, Luo W, Wu G, Cui S, Zhang Z, Gu X. Open versus endoscopic carpal tunnel release: a systematic review and meta-analysis of randomized controlled trials. BMC Musculoskeletal Disorders. 2020;21:272. DOI: 10.1186/s12891-020-03306-1.
- Lusa V, Karjalainen TV, Pääkkönen M, Rajamäki TJ, Jokihaara J. Surgical versus non-surgical treatment for carpal tunnel syndrome. Cochrane Database of Systematic Reviews. 2024;1:CD001552. DOI: 10.1002/14651858.cd001552.pub3.
NOTE: This article provides general information to help the reader better understand regenerative medicine, nerve and musculoskeletal conditions, naturopathic approaches to pain, and related subjects. All content provided in this article, website, or any linked materials, including text, graphics, images, research, and outcomes, are not intended, and should not be used, as a substitute for direct medical advice, diagnosis, or treatment. Please always consult with a professional and licensed healthcare provider to discuss if any treatment is right for you.